FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

Preserve Covid-19 Vaccine Records: Senator

Republican Sen. Ron Johnson orders FDA, HHS, and CDC to preserve all records relating to Covid-19 vaccines, saying they will be subpoenaed if they are...

latest-news-card-1
Human Drugs

CDER Deputy Throckmorton Retiring in January

CDER deputy director for regulatory programs Doug Throckmorton announces his retirement after 27 years at the agency.

latest-news-card-1
Federal Register

FDA Revokes EUAs on Covid Tests

Federal Register notice: FDA revokes the Emergency Use Authorizations issued to Cue Health for the Cue Covid19 Test, and Cue Covid19 Home/OTC Test.

latest-news-card-1
Federal Register

FDA Provides More Draft ANDA-Specific Guidances

Federal Register notice: FDA makes available additional draft and revised draft product-specific guidances for generic drug sponsors.

latest-news-card-1
Human Drugs

Fludarabine Phosphate Labeling Changes OKd

FDA announces approved labeling changes for Sandoz fludarabine phosphate injection under the Oncology Center of Excellences Project Renewal.

latest-news-card-1
Medical Devices

FDA Clears Ultromics EchoGo Amyloidosis Device

FDA clears an Ultromics 510(k) for the EchoGo Amyloidosis for detecting cardiac amyloidosis.

latest-news-card-1
Human Drugs

Sage Ending Dalzanemdor Development

Sage says it is ending dalzanemdor development in Huntingtons disease cognitive impairment following Phase 2 DIMENSION results that did not meet prima...

latest-news-card-1
Human Drugs

FDA Warns Unexo Lifesciences Over CGMP

FDA warns New Delhi, India-based Unexo Lifesciences about CGMP and other violations in its production of finished drugs.

latest-news-card-1
Human Drugs

FDA Finds CGMP Violations in Originitalia Inspection

FDA warns Italys Originitalia about CGMP violations in its production of finished drugs.

latest-news-card-1
Human Drugs

Put Semaglutide Drugs on DDC Lists: Novo Nordisk

Novo Nordisk petitions FDA to take specific steps to follow through on the companys nomination of semaglutide (Rybelsus, Ozempic, Wegovy) to the lists...